Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate/GABA-glutamine cycle
JV Andersen, A Schousboe, A Verkhratsky - Progress in neurobiology, 2022 - Elsevier
Astrocytes contribute to the complex cellular pathology of Alzheimer's disease (AD).
Neurons and astrocytes function in close collaboration through neurotransmitter recycling …
Neurons and astrocytes function in close collaboration through neurotransmitter recycling …
Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning
MT Kabir, MS Uddin, M Begum… - Current …, 2019 - ingentaconnect.com
In the brain, acetylcholine (ACh) is regarded as one of the major neurotransmitters. During
the advancement of Alzheimer's disease (AD) cholinergic deficits occur and this can lead to …
the advancement of Alzheimer's disease (AD) cholinergic deficits occur and this can lead to …
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits
LM Bierer, V Haroutunian, S Gabriel… - Journal of …, 1995 - Wiley Online Library
Cholinergic markers, neuropeptides, and amines and their metabolites were sampled from
identical specimens across 10 neocortical regions in a large sample of Alzheimer's disease …
identical specimens across 10 neocortical regions in a large sample of Alzheimer's disease …
Quantitative assessment of cortical synaptic density in Alzheimer's disease
SW Scheff, ST DeKosky, DA Price - Neurobiology of aging, 1990 - Elsevier
Significant progress has been made over the last decade in delineating the
neuropathological and neurochemical changes in the brains of patients with Alzheimer's …
neuropathological and neurochemical changes in the brains of patients with Alzheimer's …
The discovery of Alzheimer‐causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”
J Hardy - The FEBS journal, 2017 - Wiley Online Library
The cloning of APP and genetic analysis of families with Alzheimer's disease were both
reported in 1987 and much present work on the disease is based upon the foundations laid …
reported in 1987 and much present work on the disease is based upon the foundations laid …
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
MA Smith, RK Kutty, PL Richey, SD Yan… - The American journal …, 1994 - ncbi.nlm.nih.gov
Heme oxygenase-1 is an important enzyme that degrades heme, a pro-oxidant, leading to
the formation of antioxidant molecules. In this study we demonstrate by …
the formation of antioxidant molecules. In this study we demonstrate by …
The cholinergic hypothesis—ten years on
EK Perry - British Medical Bulletin, 1986 - academic.oup.com
The cholinergic hypothesis of Alzheimer's disease originally postulated a connection
between some of the cognitive impaiments of this disorder, particularly memory, and a …
between some of the cognitive impaiments of this disorder, particularly memory, and a …
Excitatory amino acids and Alzheimer's disease
JT Greenamyre, AB Young - Neurobiology of aging, 1989 - Elsevier
Excitatory amino acids (EAA) such as glutamate and aspartate are major transmitters of the
cerebral cortex and hippocampus and EAA mechanisms appear to play a role in learning …
cerebral cortex and hippocampus and EAA mechanisms appear to play a role in learning …
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation
DC Mash, DD Flynn, LT Potter - Science, 1985 - science.org
Cerebral cortex samples from patients with Alzheimer's disease and from rats after
experimental cholinergic denervation of the cerebral cortex exhibited reductions in the …
experimental cholinergic denervation of the cerebral cortex exhibited reductions in the …
Alzheimer disease
MA Smith - International review of neurobiology, 1998 - Elsevier
Publisher Summary The chapter discusses the Alzheimer disease. It is described as a fatal
degenerative dementing disorder with initial mild memory impairment that progresses …
degenerative dementing disorder with initial mild memory impairment that progresses …